Zenas BioPharma (ZBIO) Tax Provisions (2025)

Zenas BioPharma's (ZBIO) quarterly Tax Provisions came in at $106000.0 in Q4 2025, up 430.0% quarter-over-quarter from $20000.0 in Q2 2025.

Zenas BioPharma (ZBIO) Tax Provisions (2025) Analysis & Trends

Zenas BioPharma's Tax Provisions history runs 1 years deep, the most recent figure standing at $106000.0 for Q4 2025.

On a quarterly basis, Tax Provisions changed N/A year-over-year to $106000.0 in Q4 2025; TTM through Dec 2025 was -$79000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$79000.0, down 118.41% from the prior year.
Tax Provisions advanced to $106000.0 in Q4 2025 per ZBIO's latest filing, from $20000.0 in the prior quarter.
Across five years, Tax Provisions topped out at $106000.0 in Q4 2025 and bottomed at -$205000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	125,146.46
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	31.86 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	179.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Zenas BioPharma	1.72 Bn	1.72 Bn	-	-

Download Data